Literature DB >> 2431137

Systemic immunity developing from intrauterine antigen exposure in the nonpregnant rat.

I J Lande.   

Abstract

This report provides a simplified model for investigating the antigen handling mechanisms of the mammalian uterus. The effectiveness of the uterus as a site for systemic immunization has been studied using a hapten-protein conjugate (DNP-BGG) as antigen in nonpregnant virgin rats. The data indicate that although the uterus is inefficient as an antigen delivery site, strong systemic immune responses can be generated under appropriate conditions. Intrauterine (i.u.) immunization with alum-precipitated DNP-BGG did not induce significant antibody activity but primed the females so that vigorous anamnestic responses were produced after a second exposure to (soluble) antigen. The following results were obtained: (1) The optimal immunization dose was 100-2000 micrograms. (2) Alum-precipitation of the immunizing antigen was necessary in order to sensitize the female, while inclusion of killed Bordetella pertussis organisms was not. (3) The site of challenge after i.u. immunization affected the level of serum antibody activity. (4) Retention of antigen within the uterus for as little as 1 day sensitized the females as effectively as 28 days' exposure. (5) The presence or absence of ovarian hormones had no apparent effect in this system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431137     DOI: 10.1016/0165-0378(86)90025-2

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  2 in total

1.  Effect of uterine immunization and oestradiol on specific IgA and IgG antibodies in uterine, vaginal and salivary secretions.

Authors:  C R Wira; C P Sandoe
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

2.  Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.

Authors:  A C Menge; S M Michalek; M W Russell; J Mestecky
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.